Advisory Board

Hilary Sutcliffe

Hilary Sutcliffe

Director of SocietyInside

About Hilary Sutcliffe

Hilary Sutcliffe is the Director of SocietyInside and was previously the Director of MATTER and the Responsible Nano Forum, which she founded in 2007. Prior to that she ran Shared View, a consultancy specialising in multi-stakeholder involvement & communications.

Hilary sits on the World Economic Forum Global Futures Council on Human Rights, and, prior to that, the Global Agenda Council on Nanotechnologies. She advises the Responsible Research and Innovation Steering Group at the University of Sheffield and she serves on the Governance Sub-Group of the UK Synthetic Biology Leadership Council. Furthermore, she is on the External Advisory Board of the Institute of Innovation Research at the Manchester Business School, University of Manchester, and the Advisory Board of SynbioChem, the Centre for Synbio & speciality fine chemicals.

Ms. Sutcliffe previously was a Non-Executive Director of EIRIS (the Ethical Investment Research Service), and the External Advisory Board of the University of Michigan Risk Science Centre in the USA. She is a member of the Advisory Board of PRISMA project and previously chaired the Advisory Board of ResAgora, a research project which explored a Responsible Innovation Framework for Europe. Additionally she was on the advisory board of the Public Dialogue on applications of Nanotechnologies, a member of Amnesty International UK Business Group, and was involved in the Royal Society of Arts Inquiry into Tomorrow’s Company.

Prof dr. Dirk Stemerding

Prof dr. Dirk Stemerding

Rathenau Institute

About Dirk Stemmerding

Prof dr. Dirk Stemerding has been working as a senior researcher of Technology Assessment at the Dutch Rathenau Instituut. He was one of the co-authors of the Rathenau study Getting to the core of the bio-economy: a perspective on the sustainable promise of biomass (2011).

He has been leading a work package on synthetic biology in the European project Global Ethics in Science & Technology (GEST 2011-2014) and was one of the editors of the volume Science and Technology Governance and Ethics: a global perspective from Europe, India and China (Springer 2015).

He was also involved as work package leader in a four-year European Mobilisation and Mutual Learning Action Plan aiming at responsible research and innovation in synthetic biology (SYNENERGENE 2013-2017). Since his retirement he is working as an independent researcher on issues relating to biotechnology & society.

Dr. Todd Kuiken

Dr. Todd Kuiken

North Carolina State University

About Dr. Todd Kuiken

Dr. Todd Kuiken is a Senior Research Scholar at the Genetic Engineering & Society Center at North Carolina State University.

Prior to that, Dr. Kuiken was a Senior Program Associate with the Science and Technology Innovation Program at the Wilson Center where he explored the scientific and technological frontier, stimulating discovery and bringing new tools to bear on public policy challenges that emerge as science advances.

He was the principal investigator on the Wilson Center’s Synthetic Biology Project, where he had numerous projects evaluating and designing new research and governance strategies to proactively address the biosafety, biosecurity and environmental risks associated with synthetic biology.

Dr. Kuiken was recently appointed to the United Nations Convention on Biological Diversity Ad-Hoc Technical Expert Group. He is also a member of the human practices committee of the International Genetically Engineered Machines competition and a founding member of its biosafety/biosecurity committee.

Dr. Carolin Kranz

Dr. Carolin Kranz


About Dr. Carolin Kranz

Dr. Carolin Kranz is responsible for the political and stakeholder communication of the issue nanotechnology in the Communications & Government Relations department of BASF. She is a member of the BASF NanoCore Team, the BASF committee responsible for the group-wide management of nanotechnology EHS and communication issues.

Carolin Kranz hosts the BASF Dialogforum Nano. After a basic course in chemistry at the University of Stuttgart, Germany she graduaded as an engineer from the Ecole Européenne des Hautes Etudes des Industries Chimiques de Strasbourg in France. From the Saarland University she received a Ph.D. in Chemistry in 1994. In 1994 she joined BASF as a R&D chemist. Assignments in the Corporate Communication and EHS departments with focus sustainability followed before she moved to the Government Relations department in 2006.

Carolin Kranz holds mandates for BASF in several nanotechnology working groups of industry associations. She participates in the NanoDialog of the German Federal Ministry for the Environment which started 2006 and lasts until today. As a Member of the Advisory Board, she supported the EU-funded NanoDiode Project. Currently she is a member of the Advisory Boards of the European Union’s H2020-funded PRISMA and GoNano projects.

Dr. David Carlander

Dr. David Carlander

Nanotechnology Industries Association

About Dr. David Carlander

Dr. Carlander is Director of Regulatory Affairs for Nanotechnology Industries Association (NIA). He joined NIA in 2011 as a Director of Advocacy. In his position, he is covering the many sectors (e.g. food, feed, ag-chem), REACH and risk assessment of nanomaterials. He is coordinating and participating in a number of various research projects and is representing NIA at EU regulatory meetings (e.g. European Commission Sub Group on Nanomaterials under REACH) and at meetings organised by the European Chemicals Agency (ECHA) for accredited stakeholders.

Before joining NIA Dr. Carlander worked six years as Scientific Officer for the European Food Safety Authority (EFSA), where he was coordinating the risk assessment of applications of nanotechnologies. Before EFSA, Dr. Carlander worked for the Swedish Ministry as well as the Swedish National Food Administration. Dr. Carlander has (co)authored around 40 publications and has over 20 years of experience working with governments, academia, industry and international organisations. Dr. Carlander holds a M.Sc. in Biotechnology and a PhD from Uppsala University, Sweden.